The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine ...

Moderna has pulled the filing for FDA approval of its flu/COVID combination vaccine. The biotech plans to resubmit later this year with the phase 3 flu vaccine efficacy data the agency wants to see.

Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market hours. Here’s what you need to know. Moderna met analysts’ revenue expectations last ...

As a result, Moderna's shares have suffered, falling more than 90% since their peak in 2021. Now let's consider where Moderna will be a few years from now. The company recently said it aims to ...

Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...

Moderna has suffered its second PMCPA rebuke in quick succession. Days after ruling Moderna had brought discredit on the industry, the U.K. self-regulatory body reached the same damning conclusion ...

Moderna’s shares climbed in the first half of the year, as it scored victories with a product approval and solid clinical trial results. This week the biotech surprised investors with some ...

1 อาการไม่รุนแรง บางคน ... mRNA วัคซีน ได้แก่ (Pfizer, Moderna) ง. โปรตีนสับยูนิต ได้แก่ Novavax 2 วัคซีนทุกตัวมี ...

Vaccine maker Moderna and computing giant IBM are teaming up to explore how quantum computing and artificial intelligence can develop future mRNA medicines, both companies announced on Thursday ...

BOSTON, April 11 (Reuters) - Moderna Inc (MRNA.O), opens new tab said on Tuesday its experimental flu vaccine did not meet the criteria for "early success" in a late-stage trial, and its shares ...

Moderna was criticized for considering a price hike for its shot. Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it ...

Amid a torrent of biotech layoffs, Massachusetts mRNA star Moderna is staffing up big time, and the company’s new chief technical operations officer figures this is just the start. Eyeing ...